title: [Role of somatostatin in the treatment of intestinal fistulas].
abstract: Somatostatin is a peptide hormone which inhibits the secretion of the growth hormone, and has proved to be a powerful inhibitor of exocrine pancreatic, gastric and intestinal secretion. It was therefore used as an adjuvant therapy in the conservative treatment of two children of eight and nine years old with fistulas of the small intestine. The first case was a colonic fistula for cecal defect, surgical intervention was carried out because treatment during 14 days with hormonal treatment after the third consecutive day of somatostatin application. In this study the authors present their experience with somatostatin, with particular emphasis on the indications contraindications, doses and lines for administration.
authors.forename: J
authors.initials: J
authors.lastname: Gonzálvez
authors.forename: J M
authors.initials: JM
authors.lastname: Ribó
authors.forename: A
authors.initials: A
authors.lastname: Montaner
authors.forename: I
authors.initials: I
authors.lastname: Claret
mesh_terms: D000008:Abdominal Neoplasms / Q000601:surgery; D001062:Appendectomy / Q000009:adverse effects; D002051:Burkitt Lymphoma / Q000601:surgery; D002648:Child; D003108:Colonic Diseases / Q000188:drug therapy / Q000209:etiology / Q000601:surgery*; D005260:Female; D006801:Humans; D007412:Intestinal Fistula / Q000188:drug therapy / Q000209:etiology / Q000601:surgery*; D008297:Male; D011183:Postoperative Complications; D013004:Somatostatin / Q000627:therapeutic use*
chemical_list: D013004:Somatostatin
vernacular_title: Papel de la somatostatina en el tratamiento de las fistulas digestivas.